Healthcare Triangle, Inc.
HCTINasdaqTechnology · Services-Computer Integrated Systems Design · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $13.9M | $11.7M | $33.2M | $45.9M | $35.3M | $31.3M |
| Operating income | −$9.8M | −$4.8M | −$7.7M | −$10.4M | −$5.4M | $1.2M |
| Net income | −$9.5M | −$6.0M | −$8.7M | −$9.6M | −$5.9M | $2.4M |
| Total assets | $22.7M | $2.0M | $6.9M | $20.8M | $24.6M | $11.1M |
| Total liabilities | — | $7.1M | $8.2M | $8.4M | $8.5M | $6.8M |
| Equity | $9.9M | −$5.1M | −$1.4M | $12.5M | $16.1M | $4.3M |
| EPS (diluted) | $-152.30 | $-16909.30 | $-2.08 | $-2.63 | $-0.20 | $0.08 |
| Shares out. | 45.2M | 4.6M | 41.7M | 41.7M | 35.9M | 27.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −70.5%
- Net margin
- −68.2%
- Return on equity
- −95.3%
- Return on assets
- −41.7%
- Return on capital (ROCE)
- −98.4%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.22
- Revenue growth (YoY)
- 18.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 31.0%high accruals
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 warning● 1 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Qmissed a reporting deadline ↗May 9, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2024
- NT 10-Qmissed a reporting deadline ↗May 16, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Orca Capital AgPassive (13G)Mar 5, 2026
- East West Capital, LlcPassive (13G)Dec 15, 2025
- L1 Capital Global Opportunities Master Fund, Ltd.Passive (13G)Aug 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Kannappan LakshmananOfficer — Business Head | Mar 31, 2025 | J | 304,180 | $0.00 |
| Kizhakevilayil ShibuOfficer — Head of M&A | Mar 31, 2025 | J | 34,129 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 379,248 | 1.0 | +140.4% |
| Apr 30, 2026 | 157,727 | 1.1 | -11.9% |
| Apr 15, 2026 | 179,026 | 1.0 | -31.0% |
| Mar 31, 2026 | 259,294 | 1.0 | +152.7% |
| Mar 13, 2026 | 102,611 | 1.0 | -85.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreementApr 10, 2026
- Other material eventMar 11, 2026
- Entered a material agreement · Regulation FD disclosureFeb 27, 2026
- Modified shareholder rights · Amended charter or bylaws · Other material eventFeb 13, 2026
- Shareholder voteFeb 6, 2026
- Entered a material agreement · Completed an acquisition or disposition · Unregistered equity sale · Regulation FD disclosureJan 28, 2026
- Entered a material agreement · Regulation FD disclosureDec 10, 2025
- Shareholder voteDec 2, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QQUARTERLY REPORTMay 14, 2026
- 10-K/AAMENDMENT NO. 1 TO FORM 10-KApr 16, 2026
- 10-KANNUAL REPORTApr 15, 2026
- 8-KCURRENT REPORTApr 10, 2026
- 8-K/AAMENDMENT NO. 1 TO FORM 8-KApr 7, 2026
- NT 10-KNOTIFICATION OF LATE FILINGMar 31, 2026
- 424B5PROSPECTUS SUPPLEMENTMar 31, 2026
- 8-KCURRENT REPORTMar 11, 2026
- SCHEDULE 13G/AMar 5, 2026
- SCHEDULE 13GMar 2, 2026
- 8-KCURRENT REPORTFeb 27, 2026
- 424B5PROSPECTUS SUPPLEMENTFeb 27, 2026
- 8-KCURRENT REPORTFeb 13, 2026
- 8-KCURRENT REPORTFeb 6, 2026
- 8-KCURRENT REPORTJan 28, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.